Aceragen Inc Com (ACGN:NASDAQ) shot up at $0.9, a gain of 42.1%. On Wed, Jul 26, 2023, ACGN:NASDAQ touched a New 2-Week Intraday Low of $0.59. From Wed, Jul 12, 2023, the stock recorded 10.00% Up Days and 27.27% Green Days
The stock spiked on Wed, May 03, 2023 at $5.37 with a volume of 16M+.
About Aceragen Inc Com (ACGN:NASDAQ)
Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases.
Top 10 Gainers:
- Mallinckrodt plc (MNK:NYSEMKT), 186.36%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 166.67%
- Vicor Corporation (VICR:NASDAQ), 57.72%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- AERWINS Technologies Inc Com (AWIN:NASDAQ), 44.93%
- Tupperware Brands Corporation (TUP:NYSE), 42.86%
- Aceragen Inc Com (ACGN:NASDAQ), 42.06%
- Armata Pharmaceuticals Inc. (ARMP:NYSEMKT), 39.09%
- NLS Pharmaceutics Ltd. (NLSP:NASDAQ), 38.41%
- SCWorx Corp. (WORX:NASDAQ), 33.44%